These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9165672

  • 1. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan.
    Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E.
    Shock; 1997 May; 7(5):364-70. PubMed ID: 9165672
    [Abstract] [Full Text] [Related]

  • 2. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
    Wanecek M, Rudehill A, Hemsén A, Lundberg JM, Weitzberg E.
    Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
    [Abstract] [Full Text] [Related]

  • 3. Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock.
    Wanecek M, Weitzberg E, Alving K, Rudehill A, Oldner A.
    Acta Anaesthesiol Scand; 2001 Nov; 45(10):1262-70. PubMed ID: 11736680
    [Abstract] [Full Text] [Related]

  • 4. The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.
    Oldner A, Wanecek M, Goiny M, Weitzberg E, Rudehill A, Alving K, Sollevi A.
    Gut; 1998 May; 42(5):696-702. PubMed ID: 9659167
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelin(A)-receptor antagonism attenuates pulmonary hypertension in porcine endotoxin shock.
    Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E.
    Eur Respir J; 1999 Jan; 13(1):145-51. PubMed ID: 10836339
    [Abstract] [Full Text] [Related]

  • 7. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
    Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E.
    Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
    [Abstract] [Full Text] [Related]

  • 8. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
    Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A.
    Eur J Pharmacol; 1999 Dec 15; 386(2-3):235-45. PubMed ID: 10618475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.
    Iskit AB, Guc MO.
    Eur J Pharmacol; 2001 Mar 02; 414(2-3):281-7. PubMed ID: 11239929
    [Abstract] [Full Text] [Related]

  • 11. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock.
    Yamamoto S, Burman HP, O'Donnell CP, Cahill PA, Robotham JL.
    Am J Physiol; 1997 Mar 02; 272(3 Pt 2):H1239-49. PubMed ID: 9087598
    [Abstract] [Full Text] [Related]

  • 12. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
    Pearl JM, Wellmann SA, McNamara JL, Lombardi JP, Wagner CJ, Raake JL, Nelson DP.
    Ann Thorac Surg; 1999 Nov 02; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
    [Abstract] [Full Text] [Related]

  • 13. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
    Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M.
    Arthritis Rheum; 2007 Jun 02; 56(6):1985-93. PubMed ID: 17530638
    [Abstract] [Full Text] [Related]

  • 14. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
    Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ.
    Lancet; 2001 Oct 06; 358(9288):1119-23. PubMed ID: 11597664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin.
    Carteaux JP, Roux S, Siaghy M, Schjöth B, Dolofon P, Bechamps Y, Mertes PM, Villemot JP.
    Eur J Cardiothorac Surg; 1999 Mar 06; 15(3):346-52. PubMed ID: 10333034
    [Abstract] [Full Text] [Related]

  • 17. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock.
    Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH.
    Crit Care Med; 2003 Jan 06; 31(1):203-10. PubMed ID: 12545016
    [Abstract] [Full Text] [Related]

  • 18. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
    Kuntzen C, Gülberg V, Gerbes AL.
    Gastroenterology; 2005 Jan 06; 128(1):164-8. PubMed ID: 15633133
    [Abstract] [Full Text] [Related]

  • 19. Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats.
    Filep JG.
    Br J Pharmacol; 2000 Mar 06; 129(5):975-83. PubMed ID: 10696098
    [Abstract] [Full Text] [Related]

  • 20. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.
    Oldner A, Wanecek M, Weitzberg E, Sundin P, Sollevi A, Rubio C, Hellström PM, Alving K, Rudehill A.
    Br J Pharmacol; 1999 Aug 06; 127(8):1793-804. PubMed ID: 10482909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.